BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2523551)

  • 1. [Usefulness of several laboratory tests on prethrombotic status in arterial vascular pathology].
    Arosio E; Lechi C; Pancera P
    Recenti Prog Med; 1989 Jan; 80(1):18-24. PubMed ID: 2523551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
    Burrows AW
    Horm Metab Res Suppl; 1981; 11():22-5. PubMed ID: 6172350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
    Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
    Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-thromboglobulin levels and atherosclerosis. Its relationship with the presence of risk factors].
    Millán Núñez-Cortés J; Marchena MJ; Lorenzo A; Mangas A; García Rojas JF; García Calzado MC
    Rev Clin Esp; 1992 Feb; 190(3):111-4. PubMed ID: 1532862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of specific platelet activation markers with carotid arterial wall thickness.
    Ghaddar HB; Cortes J; Salomaa V; Kark JD; Davis CE; Folsom AR; Heiss G; Stinson V; Wu KK
    Thromb Haemost; 1995 Sep; 74(3):943-8. PubMed ID: 8571326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?
    Gershlick AH
    Circulation; 1990 Jan; 81(1 Suppl):I28-34; discussion I40-1. PubMed ID: 2136816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

  • 10. Markers of thrombotic activity in arterial disease.
    Donaldson MC; Matthews ET; Hadjimichael J; Rickles FR
    Arch Surg; 1987 Aug; 122(8):897-900. PubMed ID: 2957982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological manifestations of a prethrombotic state in developmental Crohn's disease].
    Chamouard P; Grunebaum L; Duclos B; Wiesel L; Cazenave JP
    Gastroenterol Clin Biol; 1990; 14(3):203-8. PubMed ID: 2188861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
    Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
    Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
    Papp AC; Hatzakis H; Bracey A; Wu KK
    Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of fibrinogen in arterial vascular pathology].
    Colorio CC; Falcón CR; Carreras LO
    Sangre (Barc); 1997 Feb; 42(1):47-52. PubMed ID: 9097719
    [No Abstract]   [Full Text] [Related]  

  • 16. The application of polyethylene glycol to radioimmunoassays used in haemostasis.
    Woodhams BJ; Kernoff PB
    Thromb Res; 1983 Feb; 29(3):333-41. PubMed ID: 6189241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets.
    Sander HJ; Slot JW; Bouma BN; Bolhuis PA; Pepper DS; Sixma JJ
    J Clin Invest; 1983 Oct; 72(4):1277-87. PubMed ID: 6195190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of thromboembolic diseases: what to do now that the radioimmunoassay has arrived.
    Handin RI
    West J Med; 1981 Jul; 135(1):50-1. PubMed ID: 6455013
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.